Concepedia

N Iqbal

NI

11

Publications

516

Citations

11

H-Index

1998

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

AstraZeneca (United States)

Bristol-Myers Squibb (Sweden)

Bristol-Myers Squibb (Germany)

AstraZeneca (Netherlands)

N Iqbal is an author at Bristol-Myers Squibb (United States) specializing in medicine, diabetes, and obesity.

Top concepts

MedicineObesityDiabetesAtherosclerosisMetabolic SyndromeCardiovascular DiseaseHealthPharmacologyHealth PolicyPublic Health

Publications per year

1998–2023

11

Publications

11

Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects.

G. Boden, Xiaohong Chen, N Iqbal · Diabetes · 1998 · 133 citations

Insulin Signaling, Obesity, Metabolic Syndrome +18

Serum resistin is not associated with obesity or insulin resistance in humans.

N Iqbal, Prakash Seshadri, Linda Stern et al. · PubMed · 2005 · 82 citations

Efficacy and safety of triple therapy with dapagliflozin add‐on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetes

Chantal Mathieu, Marisol Herrera Marmolejo, José Gerardo González‐González et al. · Diabetes Obesity and Metabolism · 2016 · 62 citations

Obesity, Metabolic Syndrome, Diabetes Management +13

Saxagliptin improves glycaemic control and C‐peptide secretion in latent autoimmune diabetes in adults (LADA)

Raffaella Buzzetti, Paolo Pozzilli, Robert Frederich et al. · Diabetes/Metabolism Research and Reviews · 2015 · 61 citations

The effects of a low-carbohydrate versus low-fat diet on adipocytokines in severely obese adults: three-year follow-up of a randomized trial.

Serena Cardillo, Prakash Seshadri, N Iqbal · PubMed · 2006 · 56 citations

Rows per page

1–5 of 11